Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances

Daily Values

Growth Metrics

IGC Pharma (IGC) Acquisitions (2017 - 2019)

IGC Pharma has reported Acquisitions over the past 8 years, most recently at $19000.0 for Q3 2019.

Quarterly Acquisitions rose 137.5% to $19000.0 in Q3 2019 from the year-ago period, while the trailing twelve-month figure was $55000.0 through Sep 2019, up 193.22% year-over-year, with the annual reading at $45000.0 for FY2019, 30.77% down from the prior year.
Acquisitions was $19000.0 for Q3 2019 at IGC Pharma, up from $4000.0 in the prior quarter.
Over five years, Acquisitions peaked at $149000.0 in Q4 2017 and troughed at -$221000.0 in Q1 2018.
The 5-year median for Acquisitions is $4500.0 (2018), against an average of $146.17.
Year-over-year, Acquisitions plummeted 3862.56% in 2016 and then soared 137.5% in 2019.
A 5-year view of Acquisitions shows it stood at -$414.0 in 2015, then plummeted by 3862.56% to -$16405.0 in 2016, then surged by 1008.26% to $149000.0 in 2017, then plummeted by 80.54% to $29000.0 in 2018, then plummeted by 34.48% to $19000.0 in 2019.
Per Business Quant, the three most recent readings for IGC's Acquisitions are $19000.0 (Q3 2019), $4000.0 (Q2 2019), and $3000.0 (Q1 2019).